111:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
heimers Dis Other Demen:@0.099709:0.082219:0.243889:0.082219:0.243889:0.069944:0.099709:0.069944:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004563:0.003257:0.008749:0.002352:0.004563:0.003257:0.010219:0.003986:0.007173:0.007644:0.003540:0.003257:0.008749:0.007644:0.011030:0.007644:0.007173
. 2011;26(3):169-83.:@0.243877:0.082219:0.350922:0.082219:0.350922:0.069944:0.243877:0.069944:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
19.  seitz Dp, Adunuri N, Gill ss, Gruneir A, Herrmann N, Rochon p. Anti-:@0.076190:0.093139:0.480956:0.093139:0.480956:0.080863:0.076190:0.080863:0.006515:0.006515:0.003257:0.003257:0.003975:0.005856:0.007644:0.002352:0.003986:0.004998:0.003881:0.008749:0.006961:0.003257:0.003881:0.008702:0.008055:0.007150:0.007173:0.007150:0.003540:0.002352:0.003869:0.008702:0.003257:0.003881:0.010254:0.002352:0.002352:0.002352:0.003881:0.005856:0.005856:0.003257:0.003881:0.010254:0.003540:0.007150:0.007173:0.007644:0.002352:0.003540:0.003869:0.008702:0.003257:0.003881:0.008032:0.007644:0.003540:0.003540:0.011030:0.008032:0.007173:0.007173:0.003869:0.008702:0.003257:0.003881:0.007138:0.007702:0.007608:0.007173:0.007702:0.007173:0.003869:0.006961:0.003257:0.003881:0.008702:0.007173:0.003986:0.002352:0.003904
depressants for agitation and psychosis in dementia. Cochrane Da-:@0.099709:0.104058:0.480944:0.104058:0.480944:0.091783:0.099709:0.091783:0.008055:0.007644:0.008020:0.003540:0.007644:0.004563:0.004563:0.008032:0.007173:0.003986:0.004563:0.002893:0.003692:0.007702:0.003540:0.002881:0.008032:0.007914:0.002352:0.003986:0.008032:0.003986:0.002352:0.007702:0.007173:0.002881:0.008032:0.007173:0.008055:0.002881:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.004563:0.002352:0.004563:0.002893:0.002352:0.007173:0.002881:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.002881:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.002881:0.008749:0.008032:0.003904
tabase syst Rev. 2011(2):CD008191.:@0.099709:0.114978:0.300181:0.114978:0.300181:0.102702:0.099709:0.102702:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
20.  Yeh YC, Ouyang WC. Mood stabilizers for the treatment of behav-:@0.076190:0.125897:0.480956:0.125897:0.480956:0.113622:0.076190:0.113622:0.006515:0.006515:0.003257:0.003257:0.003975:0.006961:0.007644:0.007173:0.003869:0.006961:0.009560:0.003257:0.003869:0.010219:0.007150:0.006303:0.008032:0.007173:0.007914:0.003869:0.011289:0.009560:0.003257:0.003869:0.010807:0.007702:0.007702:0.008055:0.003869:0.004563:0.003986:0.008032:0.008020:0.002352:0.002352:0.002352:0.004998:0.007644:0.003540:0.004563:0.003881:0.003692:0.007702:0.003540:0.003869:0.003986:0.007173:0.007644:0.003869:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003857:0.007702:0.003692:0.003869:0.008020:0.007644:0.007173:0.008032:0.006515:0.003904
ioral and psychological symptoms of dementia: An update review. :@0.099709:0.136817:0.484213:0.136817:0.484213:0.124541:0.099709:0.124541:0.002352:0.007702:0.003540:0.008032:0.002352:0.003387:0.008032:0.007173:0.008055:0.003387:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.008032:0.002352:0.003387:0.004563:0.006303:0.011030:0.008020:0.003986:0.007702:0.011030:0.004563:0.003387:0.007702:0.003692:0.003387:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003387:0.008702:0.007173:0.003375:0.007150:0.008020:0.008055:0.008032:0.003986:0.007644:0.003387:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.003257
Kaohsiung J Med Sci:@0.099709:0.147736:0.216478:0.147736:0.216478:0.135461:0.099709:0.135461:0.006950:0.008032:0.007702:0.007173:0.004563:0.002352:0.007150:0.007173:0.007914:0.003257:0.005668:0.003257:0.010807:0.007644:0.008055:0.003257:0.005856:0.007608:0.002352
. 2012;28(4):185-93.:@0.216466:0.147736:0.323511:0.147736:0.323511:0.135461:0.216466:0.135461:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
21.  Lonergan  E, Luxenberg  J. Valproate preparations for agitation in :@0.076190:0.158655:0.484213:0.158655:0.484213:0.146380:0.076190:0.146380:0.006515:0.006515:0.003257:0.003257:0.003975:0.005433:0.007702:0.007173:0.007644:0.003540:0.007914:0.008032:0.007173:0.003257:0.001964:0.006303:0.003257:0.005233:0.005433:0.007150:0.005644:0.007644:0.007173:0.008020:0.007644:0.003540:0.007914:0.003257:0.001964:0.005668:0.003257:0.005233:0.008255:0.008032:0.002352:0.008020:0.003540:0.007702:0.008032:0.003986:0.007644:0.005233:0.008020:0.003540:0.007644:0.008020:0.008032:0.003540:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.005233:0.003692:0.007702:0.003540:0.005233:0.008032:0.007914:0.002352:0.003986:0.008032:0.003986:0.002352:0.007702:0.007173:0.005233:0.002352:0.007173:0.003257
dementia. Cochrane Database syst Rev. 2009(3):CD003945.:@0.099709:0.169575:0.441080:0.169575:0.441080:0.157299:0.099709:0.157299:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003257:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
22.  Tampi RR, Tampi DJ. Efficacy and tolerability of benzodiazepines for :@0.076190:0.180494:0.484213:0.180494:0.484213:0.168219:0.076190:0.168219:0.006515:0.006515:0.003257:0.003257:0.003975:0.005009:0.008032:0.011030:0.008020:0.002352:0.003034:0.007138:0.007138:0.003257:0.003034:0.005009:0.008032:0.011030:0.008020:0.002352:0.003034:0.008749:0.005668:0.003257:0.003034:0.006303:0.003692:0.002863:0.002863:0.007608:0.008032:0.007608:0.006303:0.003034:0.008032:0.007173:0.008055:0.003034:0.003986:0.007702:0.002352:0.007644:0.003540:0.008032:0.008020:0.002352:0.002352:0.002352:0.003986:0.006303:0.003034:0.007702:0.003692:0.003034:0.008020:0.007644:0.007173:0.004998:0.007702:0.008055:0.002352:0.008032:0.004998:0.007644:0.008020:0.002352:0.007173:0.007644:0.004563:0.003034:0.003692:0.007702:0.003540:0.003257
the  treatment  of  behavioral and psychological  symptoms of  de-:@0.099709:0.191414:0.480944:0.191414:0.480944:0.179138:0.099709:0.179138:0.003986:0.007173:0.007644:0.003257:0.001929:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.001929:0.007702:0.003692:0.003257:0.001929:0.008020:0.007644:0.007173:0.008032:0.006515:0.002352:0.007702:0.003540:0.008032:0.002352:0.005198:0.008032:0.007173:0.008055:0.005198:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.008032:0.002352:0.003257:0.001929:0.004563:0.006303:0.011030:0.008020:0.003986:0.007702:0.011030:0.004563:0.005198:0.007702:0.003692:0.003257:0.001929:0.008055:0.007644:0.003904
mentia: A systematic review of randomized controlled trials. :@0.099709:0.202333:0.449911:0.202333:0.449911:0.190058:0.099709:0.190058:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.004445:0.008702:0.004433:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.004445:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.004445:0.007702:0.003692:0.004433:0.003540:0.008032:0.007173:0.008055:0.007702:0.011030:0.002352:0.004998:0.007644:0.008055:0.004433:0.007608:0.007702:0.007173:0.003986:0.003540:0.007702:0.002352:0.002352:0.007644:0.008055:0.004433:0.003986:0.003540:0.002352:0.008032:0.002352:0.004563:0.003257:0.003257
Am J :@0.451099:0.202333:0.484189:0.202333:0.484189:0.190058:0.451099:0.190058:0.008702:0.011030:0.004433:0.005668:0.003257
Alzheimers Dis Other Demen:@0.099709:0.213253:0.259940:0.213253:0.259940:0.200977:0.099709:0.200977:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004563:0.003257:0.008749:0.002352:0.004563:0.003257:0.010219:0.003986:0.007173:0.007644:0.003540:0.003257:0.008749:0.007644:0.011030:0.007644:0.007173
. 2014;29(7):565-74.:@0.259929:0.213253:0.366973:0.213253:0.366973:0.200977:0.259929:0.200977:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
23.  Verdoux H, Lagnaoui R, Begaud B. Is benzodiazepine use a risk fac-:@0.076190:0.224172:0.480944:0.224172:0.480944:0.211897:0.076190:0.211897:0.006515:0.006515:0.003257:0.003257:0.003975:0.008255:0.007644:0.003540:0.008055:0.007702:0.007150:0.005644:0.003293:0.008032:0.003257:0.003293:0.005433:0.008032:0.007914:0.007173:0.008032:0.007702:0.007150:0.002352:0.003293:0.007138:0.003257:0.003293:0.006750:0.007644:0.007914:0.008032:0.007150:0.008055:0.003293:0.006750:0.003257:0.003293:0.002658:0.004563:0.003293:0.008020:0.007644:0.007173:0.004998:0.007702:0.008055:0.002352:0.008032:0.004998:0.007644:0.008020:0.002352:0.007173:0.007644:0.003293:0.007150:0.004563:0.007644:0.003293:0.008032:0.003293:0.003540:0.002352:0.004563:0.005903:0.003293:0.003692:0.008032:0.007608:0.003904
tor for cognitive decline and dementia? A literature review of epi:@0.099709:0.235091:0.477028:0.235091:0.477028:0.222816:0.099709:0.222816:0.003986:0.007702:0.003540:0.003916:0.003692:0.007702:0.003540:0.003916:0.007608:0.007702:0.007914:0.007173:0.002352:0.003986:0.002352:0.006515:0.007644:0.003916:0.008055:0.007644:0.007608:0.002352:0.002352:0.007173:0.007644:0.003916:0.008032:0.007173:0.008055:0.003916:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.006950:0.003916:0.008702:0.003916:0.002352:0.002352:0.003986:0.007644:0.003540:0.008032:0.003986:0.007150:0.003540:0.007644:0.003916:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003916:0.007702:0.003692:0.003916:0.007644:0.008020:0.002352
-:@0.477028:0.235091:0.480932:0.235091:0.480932:0.222816:0.477028:0.222816:0.003904
demiological studies. :@0.099709:0.246011:0.222887:0.246011:0.222887:0.233735:0.099709:0.233735:0.008055:0.007644:0.011030:0.002352:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.008032:0.002352:0.003257:0.004563:0.003986:0.007150:0.008055:0.002352:0.007644:0.004563:0.003257:0.003257
Psychol Med:@0.222887:0.246011:0.295312:0.246011:0.295312:0.233735:0.222887:0.233735:0.006961:0.004563:0.006303:0.007608:0.007173:0.007702:0.002352:0.003257:0.010807:0.007644:0.008055
. 2005;35(3):307-15.:@0.295312:0.246011:0.402357:0.246011:0.402357:0.233735:0.295312:0.233735:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
24.  Leong C. Antidepressants for depression in patients with dementia: :@0.076190:0.256930:0.484213:0.256930:0.484213:0.244655:0.076190:0.244655:0.006515:0.006515:0.003257:0.003257:0.003975:0.005433:0.007644:0.007702:0.007173:0.007914:0.003575:0.009560:0.003257:0.003575:0.008702:0.007173:0.003986:0.002352:0.008055:0.007644:0.008020:0.003540:0.007644:0.004563:0.004563:0.008032:0.007173:0.003986:0.004563:0.003575:0.003692:0.007702:0.003540:0.003575:0.008055:0.007644:0.008020:0.003540:0.007644:0.004563:0.004563:0.002352:0.007702:0.007173:0.003587:0.002352:0.007173:0.003587:0.008020:0.008032:0.003986:0.002352:0.007644:0.007173:0.003986:0.004563:0.003587:0.009772:0.002352:0.003986:0.007173:0.003587:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257
a review of the literature. :@0.099709:0.267850:0.245171:0.267850:0.245171:0.255574:0.099709:0.255574:0.008032:0.003257:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.007702:0.003692:0.003257:0.003986:0.007173:0.007644:0.003257:0.002352:0.002352:0.003986:0.007644:0.003540:0.008032:0.003986:0.007150:0.003540:0.007644:0.003257:0.003257
Consult Pharm:@0.245147:0.267850:0.327627:0.267850:0.327627:0.255574:0.245147:0.255574:0.009560:0.007702:0.007173:0.004563:0.007150:0.002352:0.003986:0.003257:0.006961:0.007173:0.008032:0.003540:0.011030
. 2014;29(4):254-63.:@0.327615:0.267850:0.434659:0.267850:0.434659:0.255574:0.327615:0.255574:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
25.  Lyketsos CG, Lee HB. Diagnosis and treatment of depression in Alz-:@0.076190:0.278769:0.480956:0.278769:0.480956:0.266494:0.076190:0.266494:0.006515:0.006515:0.003257:0.003257:0.003975:0.005433:0.006303:0.005903:0.007644:0.003986:0.004563:0.007702:0.004563:0.003751:0.009560:0.010254:0.003257:0.003751:0.005433:0.007644:0.007644:0.003751:0.008032:0.006750:0.003257:0.003751:0.008749:0.002352:0.008032:0.007914:0.007173:0.007702:0.004563:0.002352:0.004563:0.003763:0.008032:0.007173:0.008055:0.003751:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003739:0.007702:0.003692:0.003751:0.008055:0.007644:0.008020:0.003540:0.007644:0.004563:0.004563:0.002352:0.007702:0.007173:0.003751:0.002352:0.007173:0.003751:0.008702:0.002352:0.004998:0.003904
heimer’s disease. A practical update for the clinician. :@0.099709:0.289689:0.404509:0.289689:0.404509:0.277413:0.099709:0.277413:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.002893:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.002893:0.008702:0.002893:0.008020:0.003540:0.008032:0.007608:0.003986:0.002352:0.007608:0.008032:0.002352:0.002893:0.007150:0.008020:0.008055:0.008032:0.003986:0.007644:0.002893:0.003692:0.007702:0.003540:0.002893:0.003986:0.007173:0.007644:0.002893:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.002352:0.008032:0.007173:0.003257:0.003257
Dement Geri-:@0.404144:0.289689:0.480956:0.289689:0.480956:0.277413:0.404144:0.277413:0.008749:0.007644:0.011030:0.007644:0.007173:0.003986:0.002893:0.010254:0.007644:0.003540:0.002352:0.003904
atr Cogn Disord:@0.099709:0.300608:0.189091:0.300608:0.189091:0.288333:0.099709:0.288333:0.008032:0.003986:0.003540:0.003257:0.009560:0.007702:0.007914:0.007173:0.003257:0.008749:0.002352:0.004563:0.007702:0.003540:0.008055
. 2004;17(1-2):55-64.:@0.189079:0.300608:0.300028:0.300608:0.300028:0.288333:0.189079:0.288333:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.003904:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
26.  Bains J, Birks J, Dening T. Antidepressants for treating depression in :@0.076190:0.311527:0.484189:0.311527:0.484189:0.299252:0.076190:0.299252:0.006515:0.006515:0.003257:0.003257:0.003975:0.006750:0.008032:0.002352:0.007173:0.004563:0.004186:0.005668:0.003257:0.004175:0.006750:0.002352:0.003540:0.005903:0.004563:0.004186:0.005668:0.003257:0.004175:0.008749:0.007644:0.007173:0.002352:0.007173:0.007914:0.004175:0.005009:0.003257:0.004175:0.008702:0.007173:0.003986:0.002352:0.008055:0.007644:0.008020:0.003540:0.007644:0.004563:0.004563:0.008032:0.007173:0.003986:0.004563:0.004186:0.003692:0.007702:0.003540:0.004175:0.003986:0.003540:0.007644:0.008032:0.003986:0.002352:0.007173:0.007914:0.004175:0.008055:0.007644:0.008020:0.003540:0.007644:0.004563:0.004563:0.002352:0.007702:0.007173:0.004186:0.002352:0.007173:0.003257
dementia. Cochrane Database syst Rev. 2002(4):CD003944.:@0.099709:0.322447:0.441080:0.322447:0.441080:0.310171:0.099709:0.310171:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003257:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
27.  Jacob  s,  spinler  sA.  Hyponatremia associated with selective :@0.076190:0.333366:0.484213:0.333366:0.484213:0.321091:0.076190:0.321091:0.006515:0.006515:0.003257:0.003257:0.003975:0.005668:0.008032:0.007608:0.007702:0.008020:0.003257:0.005656:0.005856:0.003257:0.003257:0.005656:0.005856:0.008020:0.002352:0.007173:0.002352:0.007644:0.003540:0.003257:0.005656:0.005856:0.008702:0.003257:0.003257:0.005644:0.008032:0.006303:0.008020:0.007702:0.007173:0.008032:0.003986:0.003540:0.007644:0.011030:0.002352:0.008032:0.008914:0.008032:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.007644:0.008055:0.008914:0.009772:0.002352:0.003986:0.007173:0.008914:0.004563:0.007644:0.002352:0.007644:0.007608:0.003986:0.002352:0.006515:0.007644:0.003257
serotonin-re-uptake  inhibitors in older adults. :@0.099709:0.344286:0.363645:0.344286:0.363645:0.332010:0.099709:0.332010:0.004563:0.007644:0.003540:0.007702:0.003986:0.007702:0.007173:0.002352:0.007173:0.003904:0.003540:0.007644:0.003904:0.007150:0.008020:0.003986:0.008032:0.005903:0.007644:0.003257:0.002658:0.002352:0.007173:0.007173:0.002352:0.008020:0.002352:0.003986:0.007702:0.003540:0.004563:0.005927:0.002352:0.007173:0.005927:0.007702:0.002352:0.008055:0.007644:0.003540:0.005927:0.008032:0.008055:0.007150:0.002352:0.003986:0.004563:0.003257:0.003257
Ann Pharmacother:@0.366315:0.344286:0.477710:0.344286:0.477710:0.332010:0.366315:0.332010:0.008702:0.007173:0.007173:0.005927:0.006961:0.007173:0.008032:0.003540:0.011030:0.008032:0.007608:0.007702:0.003986:0.007173:0.007644:0.003540
. :@0.477698:0.344286:0.484213:0.344286:0.484213:0.332010:0.477698:0.332010:0.003257:0.003257
2006;40(9):1618-22.:@0.099709:0.355205:0.206753:0.355205:0.206753:0.342930:0.099709:0.342930:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
28.  McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, :@0.076190:0.366125:0.469196:0.366125:0.469196:0.353849:0.076190:0.353849:0.006515:0.006515:0.003257:0.003257:0.003975:0.010807:0.007608:0.006950:0.007644:0.002352:0.003986:0.007173:0.003375:0.002658:0.010254:0.003257:0.003375:0.008749:0.002352:0.007608:0.005903:0.004563:0.007702:0.007173:0.003375:0.008749:0.011289:0.003257:0.003375:0.005433:0.007702:0.009772:0.007644:0.003375:0.005668:0.003257:0.003375:0.006303:0.011030:0.003540:0.007644:0.003375:0.010807:0.003257:0.003375:0.010219:0.004127:0.006750:0.003540:0.002352:0.007644:0.007173:0.003375:0.005668:0.005009:0.003257:0.003375:0.005703:0.007644:0.002352:0.008055:0.011030:0.008032:0.007173:0.003375:0.008032:0.003257:0.003257
et :@0.469314:0.366125:0.484201:0.366125:0.484201:0.353849:0.469314:0.353849:0.007644:0.003986:0.003257
al:@0.099709:0.377044:0.110092:0.377044:0.110092:0.364769:0.099709:0.364769:0.008032:0.002352
. Diagnosis and management of dementia with Lewy bodies: third :@0.110092:0.377044:0.484213:0.377044:0.484213:0.364769:0.110092:0.364769:0.003257:0.002763:0.008749:0.002352:0.008032:0.007914:0.007173:0.007702:0.004563:0.002352:0.004563:0.002763:0.008032:0.007173:0.008055:0.002763:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.002752:0.007702:0.003692:0.002752:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.002763:0.009772:0.002352:0.003986:0.007173:0.002763:0.005433:0.007644:0.009772:0.006303:0.002763:0.008020:0.007702:0.008055:0.002352:0.007644:0.004563:0.003257:0.002763:0.003986:0.007173:0.002352:0.003540:0.008055:0.003257
report of the DLB Consortium. :@0.099709:0.387963:0.269571:0.387963:0.269571:0.375688:0.099709:0.375688:0.003540:0.007644:0.008020:0.007702:0.003540:0.003986:0.003257:0.007702:0.003692:0.003257:0.003986:0.007173:0.007644:0.003257:0.008749:0.005433:0.006750:0.003257:0.009560:0.007702:0.007173:0.004563:0.007702:0.003540:0.003986:0.002352:0.007150:0.011030:0.003257:0.003257
Neurology:@0.269536:0.387963:0.328544:0.387963:0.328544:0.375688:0.269536:0.375688:0.008702:0.007644:0.007150:0.003540:0.007702:0.002352:0.007702:0.007914:0.006303
. 2005;65(12):1863-72.:@0.328532:0.387963:0.448606:0.387963:0.448606:0.375688:0.328532:0.375688:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
29.  Ibach B, Haen E. Acetylcholinesterase inhibition in Alzheimer’s Dis-:@0.076190:0.398883:0.480944:0.398883:0.480944:0.386607:0.076190:0.386607:0.006515:0.006515:0.003257:0.003257:0.003975:0.002658:0.008020:0.008032:0.007608:0.007173:0.004363:0.006750:0.003257:0.004363:0.008032:0.008032:0.007644:0.007173:0.004363:0.006303:0.003257:0.004363:0.008702:0.007608:0.007644:0.003986:0.006303:0.002352:0.007608:0.007173:0.007702:0.002352:0.002352:0.007173:0.007644:0.004563:0.003986:0.007644:0.003540:0.008032:0.004563:0.007644:0.004351:0.002352:0.007173:0.007173:0.002352:0.008020:0.002352:0.003986:0.002352:0.007702:0.007173:0.004363:0.002352:0.007173:0.004363:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.004351:0.008749:0.002352:0.004563:0.003904
ease. :@0.099709:0.409802:0.134105:0.409802:0.134105:0.397527:0.099709:0.397527:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257
Curr Pharm Des:@0.134105:0.409802:0.222099:0.409802:0.222099:0.397527:0.134105:0.397527:0.009560:0.007150:0.003540:0.003540:0.003257:0.006961:0.007173:0.008032:0.003540:0.011030:0.003257:0.008749:0.007644:0.004563
. 2004;10(3):231-51.:@0.222087:0.409802:0.329132:0.409802:0.329132:0.397527:0.222087:0.397527:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
30.  Tan CC, Yu JT, Wang HF, Tan Ms, Meng XF, Wang C, :@0.076190:0.420722:0.402592:0.420722:0.402592:0.408446:0.076190:0.408446:0.006515:0.006515:0.003257:0.003257:0.003975:0.005009:0.008032:0.007173:0.003692:0.009560:0.009560:0.003257:0.003692:0.006961:0.007150:0.003692:0.005668:0.005009:0.003257:0.003681:0.011289:0.008032:0.007173:0.007914:0.003692:0.008032:0.005703:0.003257:0.003692:0.005009:0.008032:0.007173:0.003692:0.010807:0.005856:0.003257:0.003692:0.010807:0.007644:0.007173:0.007914:0.003669:0.007161:0.005703:0.003257:0.003681:0.011289:0.008032:0.007173:0.007914:0.003692:0.009560:0.003257:0.003257
et al:@0.403027:0.420722:0.428733:0.420722:0.428733:0.408446:0.403027:0.408446:0.007644:0.003986:0.003692:0.008032:0.002352
. Efficacy :@0.428733:0.420722:0.484213:0.420722:0.484213:0.408446:0.428733:0.408446:0.003257:0.003692:0.006303:0.003692:0.002863:0.002863:0.007608:0.008032:0.007608:0.006303:0.003257
and safety of donepezil, galantamine, rivastigmine, and meman-:@0.099709:0.431641:0.480956:0.431641:0.480956:0.419366:0.099709:0.419366:0.008032:0.007173:0.008055:0.004774:0.004563:0.008032:0.003692:0.007644:0.003986:0.006303:0.004774:0.007702:0.003692:0.004774:0.008055:0.007702:0.007173:0.007644:0.008020:0.007644:0.004998:0.002352:0.002352:0.003257:0.004774:0.007914:0.008032:0.002352:0.008032:0.007173:0.003986:0.008032:0.011030:0.002352:0.007173:0.007644:0.003257:0.004774:0.003540:0.002352:0.006515:0.008032:0.004563:0.003986:0.002352:0.007914:0.011030:0.002352:0.007173:0.007644:0.003257:0.004774:0.008032:0.007173:0.008055:0.004774:0.011030:0.007644:0.011030:0.008032:0.007173:0.003904
tine for the treatment of Alzheimer’s disease: A systematic review :@0.099709:0.442560:0.484213:0.442560:0.484213:0.430285:0.099709:0.430285:0.003986:0.002352:0.007173:0.007644:0.004610:0.003692:0.007702:0.003540:0.004610:0.003986:0.007173:0.007644:0.004610:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007632:0.007173:0.003986:0.004610:0.007702:0.003692:0.004610:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.004610:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.004610:0.008702:0.004610:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.004610:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257
and meta-analysis. :@0.099709:0.453480:0.210704:0.453480:0.210704:0.441205:0.099709:0.441205:0.008032:0.007173:0.008055:0.003257:0.011030:0.007644:0.003986:0.008032:0.003904:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.003257:0.003257
J Alzheimers Dis.:@0.210704:0.453480:0.301803:0.453480:0.301803:0.441205:0.210704:0.441205:0.005668:0.003257:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004563:0.003257:0.008749:0.002352:0.004563:0.003257
 2014;41(2):615-31.:@0.301803:0.453480:0.405591:0.453480:0.405591:0.441205:0.301803:0.441205:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
31.  Trinh NH, Hoblyn J, Mohanty S, Yaffe K. Efficacy of cholinesterase :@0.076190:0.464399:0.484213:0.464399:0.484213:0.452124:0.076190:0.452124:0.006515:0.006515:0.003257:0.003257:0.003975:0.005009:0.003540:0.002352:0.007173:0.007173:0.004833:0.008702:0.008032:0.003257:0.004833:0.008032:0.007702:0.008020:0.002352:0.006303:0.007173:0.004833:0.005668:0.003257:0.004833:0.010807:0.007702:0.007173:0.008032:0.007173:0.003986:0.006303:0.004833:0.005856:0.003257:0.004833:0.006961:0.008032:0.003692:0.003692:0.007644:0.004845:0.006950:0.003257:0.004833:0.006303:0.003692:0.002863:0.002863:0.007608:0.008032:0.007608:0.006303:0.004833:0.007702:0.003692:0.004833:0.007608:0.007173:0.007702:0.002352:0.002352:0.007173:0.007644:0.004563:0.003986:0.007644:0.003540:0.008032:0.004563:0.007644:0.003257
inhibitors in the treatment of neuropsychiatric symptoms and func-:@0.099709:0.475319:0.480956:0.475319:0.480956:0.463043:0.099709:0.463043:0.002352:0.007173:0.007173:0.002352:0.008020:0.002352:0.003986:0.007702:0.003540:0.004563:0.003822:0.002352:0.007173:0.003822:0.003986:0.007173:0.007644:0.003822:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003810:0.007702:0.003692:0.003822:0.007173:0.007644:0.007150:0.003540:0.007702:0.008020:0.004563:0.006303:0.007608:0.007173:0.002352:0.008032:0.003986:0.003540:0.002352:0.007608:0.003822:0.004563:0.006303:0.011030:0.008020:0.003986:0.007702:0.011030:0.004563:0.003822:0.008032:0.007173:0.008055:0.003822:0.003692:0.007150:0.007173:0.007608:0.003904
tional  impairment  in  Alzheimer  disease:  A  meta-analysis. :@0.099709:0.486238:0.440433:0.486238:0.440433:0.473963:0.099709:0.473963:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003257:0.003363:0.002352:0.011030:0.008020:0.008032:0.002352:0.003540:0.011030:0.007644:0.007173:0.003986:0.003257:0.003363:0.002352:0.007173:0.003257:0.003363:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.003257:0.003363:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257:0.003363:0.008702:0.003257:0.003363:0.011030:0.007644:0.003986:0.008032:0.003904:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.003257:0.003257
JAMA:@0.443808:0.486238:0.477686:0.486238:0.477686:0.473963:0.443808:0.473963:0.005668:0.008702:0.010807:0.008702
. :@0.477698:0.486238:0.484213:0.486238:0.484213:0.473963:0.477698:0.473963:0.003257:0.003257
2003;289(2):210-6.:@0.099709:0.497158:0.200239:0.497158:0.200239:0.484882:0.099709:0.484882:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.003257
32.  Raina p, santaguida p, Ismaila A, patterson C, Cowan D, Levine M, :@0.076190:0.508077:0.469455:0.508077:0.469455:0.495802:0.076190:0.495802:0.006279:0.006279:0.003022:0.003257:0.004680:0.006903:0.007796:0.002117:0.006938:0.007796:0.003363:0.006726:0.003022:0.003363:0.005621:0.007796:0.006938:0.003751:0.007796:0.007679:0.006914:0.002117:0.007820:0.007796:0.003363:0.006726:0.003022:0.003363:0.002422:0.004327:0.010795:0.007796:0.002117:0.002117:0.007796:0.003363:0.008467:0.003022:0.003363:0.006726:0.007796:0.003751:0.003751:0.007408:0.003304:0.004327:0.007467:0.006938:0.003363:0.009325:0.003022:0.003363:0.009325:0.007467:0.009537:0.007796:0.006938:0.003363:0.008514:0.003022:0.003363:0.005198:0.007408:0.006279:0.002117:0.006938:0.007408:0.003363:0.010572:0.003022:0.003257
et :@0.469561:0.508077:0.484213:0.508077:0.484213:0.495802:0.469561:0.495802:0.007408:0.003986:0.003257
al:@0.099709:0.518996:0.109857:0.518996:0.109857:0.506721:0.099709:0.506721:0.007796:0.002352
. Effectiveness of cholinesterase inhibitors and memantine for treat-:@0.109622:0.518996:0.480932:0.518996:0.480932:0.506721:0.109622:0.506721:0.003022:0.003857:0.006068:0.003457:0.003457:0.007408:0.007373:0.003751:0.002117:0.006279:0.007408:0.006938:0.007408:0.004327:0.004327:0.003857:0.007467:0.003457:0.003857:0.007373:0.006938:0.007467:0.002117:0.002117:0.006938:0.007408:0.004327:0.003751:0.007408:0.003304:0.007796:0.004327:0.007408:0.003857:0.002117:0.006938:0.006938:0.002117:0.007785:0.002117:0.003751:0.007467:0.003304:0.004327:0.003857:0.007796:0.006938:0.007820:0.003857:0.010795:0.007408:0.010795:0.007796:0.006938:0.003751:0.002117:0.006938:0.007408:0.003857:0.003457:0.007467:0.003304:0.003857:0.003751:0.003304:0.007408:0.007796:0.003751:0.003904
ing dementia: Evidence review for a clinical practice guideline. :@0.099709:0.529916:0.457543:0.529916:0.457543:0.517641:0.099709:0.517641:0.002117:0.006938:0.007679:0.004116:0.007820:0.007408:0.010795:0.007408:0.006938:0.003751:0.002117:0.007796:0.003022:0.004116:0.006068:0.006279:0.002117:0.007820:0.007408:0.006938:0.007373:0.007408:0.004116:0.003304:0.007408:0.006279:0.002117:0.007408:0.009537:0.004116:0.003457:0.007467:0.003304:0.004104:0.007796:0.004116:0.007373:0.002117:0.002117:0.006938:0.002117:0.007373:0.007796:0.002117:0.004116:0.007785:0.003304:0.007796:0.007373:0.003751:0.002117:0.007373:0.007408:0.004104:0.007679:0.006914:0.002117:0.007820:0.007408:0.002117:0.002117:0.006938:0.007408:0.003022:0.003257
Ann :@0.458401:0.529916:0.484236:0.529916:0.484236:0.517641:0.458401:0.517641:0.008467:0.006938:0.007173:0.003257
Intern Med:@0.099709:0.540835:0.159528:0.540835:0.159528:0.528560:0.099709:0.528560:0.002422:0.006938:0.003751:0.007408:0.003304:0.006938:0.003022:0.010572:0.007408:0.008055
. 2008;148(5):379-97.:@0.159293:0.540835:0.268148:0.540835:0.268148:0.528560:0.159293:0.528560:0.003022:0.003022:0.006279:0.006279:0.006279:0.006279:0.003022:0.006279:0.006279:0.006279:0.004104:0.006279:0.004104:0.003022:0.006279:0.006279:0.006279:0.003669:0.006279:0.006279:0.003257
33.  Mcshane R, Areosa sastre A, Minakaran N. Memantine for demen-:@0.076190:0.551755:0.480920:0.551755:0.480920:0.539479:0.076190:0.539479:0.006515:0.006515:0.003257:0.003257:0.003975:0.010807:0.007608:0.005856:0.007173:0.008032:0.007173:0.007644:0.003504:0.007138:0.003257:0.003504:0.008702:0.003540:0.007632:0.007702:0.004563:0.008032:0.003516:0.005856:0.008032:0.004563:0.003986:0.003540:0.007644:0.003504:0.008702:0.003257:0.003504:0.010807:0.002352:0.007173:0.008032:0.005903:0.008032:0.003540:0.008032:0.007173:0.003504:0.008702:0.003257:0.003504:0.010807:0.007644:0.011030:0.008032:0.007173:0.003986:0.002352:0.007173:0.007644:0.003504:0.003692:0.007702:0.003540:0.003504:0.008055:0.007644:0.011030:0.007644:0.007173:0.003904
tia. Cochrane Database syst Rev. 2006(2):CD003154.:@0.099709:0.562674:0.399535:0.562674:0.399535:0.550399:0.099709:0.550399:0.003986:0.002352:0.008032:0.003257:0.003257:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003257:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
34.  Matsunaga s, Kishi T, Iwata N. Combination therapy with cholinester-:@0.076190:0.573594:0.480956:0.573594:0.480956:0.561318:0.076190:0.561318:0.006515:0.006515:0.003257:0.003257:0.003975:0.010807:0.008032:0.003986:0.004563:0.007150:0.007173:0.008032:0.007914:0.008032:0.002411:0.005856:0.003257:0.002411:0.006950:0.002352:0.004563:0.007173:0.002352:0.002411:0.005009:0.003257:0.002399:0.002658:0.009772:0.008032:0.003986:0.008032:0.002411:0.008702:0.003257:0.002399:0.009560:0.007702:0.011030:0.008020:0.002352:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.002399:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.002399:0.009772:0.002352:0.003986:0.007173:0.002411:0.007608:0.007173:0.007702:0.002352:0.002352:0.007173:0.007644:0.004563:0.003986:0.007644:0.003540:0.003904
ase inhibitors and memantine for Alzheimer’s disease: A systematic :@0.099709:0.584513:0.484189:0.584513:0.484189:0.572238:0.099709:0.572238:0.008032:0.004563:0.007644:0.003575:0.002352:0.007173:0.007173:0.002352:0.008020:0.002352:0.003986:0.007702:0.003540:0.004563:0.003563:0.008032:0.007173:0.008055:0.003563:0.011030:0.007644:0.011030:0.008032:0.007173:0.003986:0.002352:0.007173:0.007644:0.003563:0.003692:0.007702:0.003540:0.003563:0.008702:0.002352:0.004998:0.007173:0.007632:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.003563:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003575:0.008702:0.003563:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.003257
review and meta-analysis. :@0.099709:0.595432:0.250298:0.595432:0.250298:0.583157:0.099709:0.583157:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.002693:0.008032:0.007173:0.008055:0.002693:0.011030:0.007644:0.003986:0.008032:0.003904:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.003257:0.003257
Int J Neuropsychopharmacol:@0.249745:0.595432:0.414210:0.595432:0.414210:0.583157:0.249745:0.583157:0.002658:0.007173:0.003986:0.002693:0.005668:0.002693:0.008702:0.007644:0.007150:0.003540:0.007702:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.008020:0.007173:0.008032:0.003540:0.011030:0.008032:0.007608:0.007702:0.002352
. 2014;18(5).:@0.414198:0.595432:0.480944:0.595432:0.480944:0.583157:0.414198:0.583157:0.003257:0.002693:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257
35.  Bond M, Rogers G, peters J, Anderson R, Hoyle M, Miners A, :@0.076202:0.606352:0.430967:0.606352:0.430967:0.594077:0.076202:0.594077:0.006515:0.006515:0.003257:0.003257:0.003975:0.006750:0.007702:0.007173:0.008055:0.002716:0.010807:0.003257:0.002716:0.007138:0.007702:0.007914:0.007644:0.003540:0.004551:0.002716:0.010254:0.003257:0.002740:0.006961:0.007644:0.003986:0.007644:0.003540:0.004563:0.002716:0.005668:0.003257:0.002716:0.008702:0.007173:0.008055:0.007644:0.003540:0.004563:0.007702:0.007173:0.002716:0.007138:0.003257:0.002716:0.008032:0.007702:0.006303:0.002352:0.007644:0.002716:0.010807:0.003257:0.002716:0.010807:0.002352:0.007173:0.007644:0.003540:0.004563:0.002716:0.008702:0.003257:0.003257
et al:@0.430438:0.606352:0.455168:0.606352:0.455168:0.594077:0.430438:0.594077:0.007644:0.003986:0.002716:0.008032:0.002352
. The :@0.455168:0.606352:0.484225:0.606352:0.484225:0.594077:0.455168:0.594077:0.003257:0.002716:0.005009:0.007173:0.007644:0.003257
effectiveness and cost-effectiveness of donepezil, galantamine, riv-:@0.099732:0.617271:0.480979:0.617271:0.480979:0.604996:0.099732:0.604996:0.007644:0.003692:0.003692:0.007644:0.007608:0.003986:0.002352:0.006515:0.007644:0.007173:0.007644:0.004563:0.004563:0.002822:0.008032:0.007173:0.008055:0.002822:0.007608:0.007702:0.004563:0.003986:0.003904:0.007644:0.003692:0.003692:0.007644:0.007608:0.003986:0.002352:0.006515:0.007644:0.007173:0.007644:0.004563:0.004563:0.002822:0.007702:0.003692:0.002810:0.008055:0.007702:0.007173:0.007644:0.008020:0.007644:0.004998:0.002352:0.002352:0.003257:0.002810:0.007914:0.008032:0.002352:0.008032:0.007173:0.003986:0.008032:0.011030:0.002352:0.007173:0.007644:0.003257:0.002822:0.003540:0.002352:0.006515:0.003904
astigmine and memantine for the treatment of Alzheimer’s disease :@0.099732:0.628191:0.484236:0.628191:0.484236:0.615915:0.099732:0.615915:0.008032:0.004563:0.003986:0.002352:0.007914:0.011030:0.002352:0.007173:0.007644:0.003469:0.008032:0.007173:0.008055:0.003469:0.011030:0.007644:0.011030:0.008032:0.007173:0.003986:0.002352:0.007173:0.007644:0.003469:0.003692:0.007702:0.003540:0.003469:0.003986:0.007173:0.007644:0.003469:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003469:0.007702:0.003692:0.003469:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.003469:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257
(review of Technology Appraisal No. 111): A systematic review and :@0.099732:0.639110:0.484236:0.639110:0.484236:0.626835:0.099732:0.626835:0.004339:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003504:0.007702:0.003692:0.003504:0.005009:0.007644:0.007608:0.007173:0.007173:0.007702:0.002352:0.007702:0.007914:0.006303:0.003492:0.008702:0.008020:0.008020:0.003540:0.008032:0.002352:0.004563:0.008032:0.002352:0.003516:0.008702:0.007702:0.003257:0.003504:0.006515:0.006515:0.006515:0.004339:0.003257:0.003516:0.008702:0.003504:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.003516:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003504:0.008032:0.007173:0.008055:0.003257
economic model. :@0.099732:0.650030:0.205107:0.650030:0.205107:0.637754:0.099732:0.637754:0.007644:0.007608:0.007702:0.007173:0.007702:0.011030:0.002352:0.007608:0.003257:0.011030:0.007702:0.008055:0.007644:0.002352:0.003257:0.003257
Health Technol Assess:@0.205095:0.650030:0.328085:0.650030:0.328085:0.637754:0.205095:0.637754:0.008032:0.007644:0.008032:0.002352:0.003986:0.007173:0.003257:0.005009:0.007644:0.007608:0.007173:0.007173:0.007702:0.002352:0.003257:0.008702:0.004563:0.004563:0.007644:0.004563:0.004563
. 2012;16(21):1-470.:@0.328085:0.650030:0.435130:0.650030:0.435130:0.637754:0.328085:0.637754:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
36.  pouryamout L, Dams J, Wasem J, Dodel R, Neumann A. Economic :@0.076226:0.660949:0.484248:0.660949:0.484248:0.648674:0.076226:0.648674:0.006515:0.006515:0.003257:0.003257:0.003975:0.006961:0.007702:0.007150:0.003540:0.006303:0.008032:0.011030:0.007702:0.007150:0.003986:0.003892:0.005433:0.003257:0.003892:0.008749:0.008032:0.011030:0.004563:0.003904:0.005668:0.003257:0.003904:0.011289:0.008032:0.004563:0.007644:0.011030:0.003904:0.005668:0.003257:0.003892:0.008749:0.007702:0.008055:0.007644:0.002352:0.003904:0.007138:0.003257:0.003904:0.008702:0.007644:0.007150:0.011030:0.008032:0.007173:0.007173:0.003892:0.008702:0.003257:0.003892:0.006303:0.007608:0.007702:0.007173:0.007702:0.011030:0.002352:0.007608:0.003257
evaluation of treatment  options in patients with Alzheimer’s dis-:@0.099744:0.671868:0.480967:0.671868:0.480967:0.659593:0.099744:0.659593:0.007644:0.006515:0.008032:0.002352:0.007150:0.008032:0.003986:0.002352:0.007702:0.007173:0.006103:0.007702:0.003692:0.006103:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.002834:0.007702:0.008020:0.003986:0.002352:0.007702:0.007173:0.004563:0.006103:0.002352:0.007173:0.006103:0.008020:0.008032:0.003986:0.002352:0.007644:0.007173:0.003986:0.004563:0.006103:0.009772:0.002352:0.003986:0.007173:0.006103:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.006103:0.008055:0.002352:0.004563:0.003904
ease: A systematic review of cost-effectiveness analyses. :@0.099744:0.682788:0.442926:0.682788:0.442926:0.670513:0.099744:0.670513:0.007644:0.008032:0.004563:0.007644:0.003257:0.006127:0.008702:0.006127:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.006127:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.006127:0.007702:0.003692:0.006127:0.007608:0.007702:0.004563:0.003986:0.003904:0.007644:0.003692:0.003692:0.007644:0.007608:0.003986:0.002352:0.006515:0.007644:0.007173:0.007644:0.004563:0.004563:0.006127:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.007644:0.004563:0.003257:0.003257
Drugs.:@0.445819:0.682788:0.480991:0.682788:0.480991:0.670513:0.445819:0.670513:0.008749:0.003540:0.007150:0.007914:0.004563:0.003257
 :@0.480991:0.682788:0.484248:0.682788:0.484248:0.670513:0.480991:0.670513:0.003257
2012;72(6):789-802.:@0.099744:0.693707:0.206789:0.693707:0.206789:0.681432:0.099744:0.681432:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
37.  Masterman DL. Role of cholinesterase inhibitors in managing behav-:@0.076226:0.704627:0.481003:0.704627:0.481003:0.692351:0.076226:0.692351:0.006515:0.006515:0.003257:0.003257:0.003975:0.010807:0.008032:0.004563:0.003986:0.007644:0.003540:0.011030:0.008032:0.007173:0.002646:0.008749:0.005433:0.003257:0.002646:0.007138:0.007702:0.002352:0.007644:0.002646:0.007702:0.003692:0.002646:0.007608:0.007173:0.007702:0.002352:0.002352:0.007173:0.007644:0.004563:0.003986:0.007644:0.003540:0.008032:0.004563:0.007644:0.002646:0.002352:0.007173:0.007173:0.002352:0.008020:0.002352:0.003986:0.007702:0.003540:0.004563:0.002646:0.002352:0.007173:0.002646:0.011030:0.008032:0.007173:0.008032:0.007914:0.002352:0.007173:0.007914:0.002646:0.008020:0.007644:0.007173:0.008032:0.006515:0.003904
ioral problems in Alzheimer’s disease. :@0.099744:0.715546:0.315656:0.715546:0.315656:0.703271:0.099744:0.703271:0.002352:0.007702:0.003540:0.008032:0.002352:0.004010:0.008020:0.003540:0.007702:0.008020:0.002352:0.007644:0.011030:0.004563:0.004022:0.002352:0.007173:0.004010:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.004010:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257
Prim Care Companion J Clin :@0.316420:0.715546:0.484225:0.715546:0.484225:0.703271:0.316420:0.703271:0.006961:0.003540:0.002352:0.011030:0.004010:0.009560:0.008032:0.003540:0.007644:0.004010:0.009560:0.007702:0.011030:0.008020:0.008032:0.007173:0.002352:0.007702:0.007173:0.004010:0.005668:0.004010:0.009560:0.002352:0.002352:0.007173:0.003257
Psychiatry:@0.099744:0.726466:0.156565:0.726466:0.156565:0.714190:0.099744:0.714190:0.006961:0.004563:0.006303:0.007608:0.007173:0.002352:0.008032:0.003986:0.003540:0.006303
. 2004;6(3):126-31.:@0.156565:0.726466:0.257095:0.726466:0.257095:0.714190:0.156565:0.714190:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
38.  Maki pM, Henderson VW. Hormone therapy, dementia, and cog-:@0.076226:0.737385:0.480991:0.737385:0.480991:0.725110:0.076226:0.725110:0.006515:0.006515:0.003257:0.003257:0.003975:0.010807:0.008032:0.005903:0.002352:0.004810:0.006961:0.010807:0.003257:0.004810:0.008032:0.007644:0.007173:0.008055:0.007644:0.003540:0.004563:0.007702:0.007173:0.004810:0.008255:0.011289:0.003257:0.004810:0.008032:0.007702:0.003540:0.011030:0.007702:0.007173:0.007644:0.004798:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003257:0.004810:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.004810:0.008032:0.007173:0.008055:0.004810:0.007608:0.007702:0.007914:0.003904
nition:  The  Women’s Health Initiative 10 years on. :@0.099744:0.748304:0.407531:0.748304:0.407531:0.736029:0.099744:0.736029:0.007173:0.002352:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257:0.004116:0.005009:0.007173:0.007644:0.003257:0.004116:0.011289:0.007702:0.011030:0.007644:0.007173:0.004127:0.004563:0.007385:0.008032:0.007644:0.008032:0.002352:0.003986:0.007173:0.007385:0.002658:0.007173:0.002352:0.003986:0.002352:0.008032:0.003986:0.002352:0.006515:0.007644:0.007385:0.006515:0.006515:0.007385:0.006303:0.007644:0.008032:0.003540:0.004563:0.007385:0.007702:0.007173:0.003257:0.003257
Climacteric.:@0.411670:0.748304:0.480991:0.748304:0.480991:0.736029:0.411670:0.736029:0.009560:0.002352:0.002352:0.011030:0.008032:0.007608:0.003986:0.007644:0.003540:0.002352:0.007608:0.003257
 :@0.480991:0.748304:0.484248:0.748304:0.484248:0.736029:0.480991:0.736029:0.003257
2012;15(3):256-62.:@0.099744:0.759224:0.200274:0.759224:0.200274:0.746949:0.099744:0.746949:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
39.  Farina N, Isaac MG, Clark AR, Rusted J, Tabet N. Vitamin E for Alz-:@0.076226:0.770143:0.480991:0.770143:0.480991:0.757868:0.076226:0.757868:0.006515:0.006515:0.003257:0.003257:0.003975:0.005703:0.008032:0.003540:0.002352:0.007173:0.008032:0.004175:0.008702:0.003257:0.004175:0.002658:0.004563:0.008032:0.008032:0.007608:0.004186:0.010807:0.010254:0.003257:0.004175:0.009560:0.002352:0.008032:0.003540:0.005903:0.004175:0.008702:0.007138:0.003257:0.004175:0.007138:0.007150:0.004563:0.003986:0.007644:0.008055:0.004175:0.005668:0.003257:0.004175:0.005009:0.008032:0.008020:0.007644:0.003986:0.004175:0.008702:0.003257:0.004175:0.008255:0.002352:0.003986:0.008032:0.011030:0.002352:0.007173:0.004175:0.006303:0.004175:0.003692:0.007702:0.003540:0.004175:0.008702:0.002352:0.004998:0.003904
heimer’s dementia and mild cognitive impairment. Cochrane Da-:@0.099744:0.781063:0.480991:0.781063:0.480991:0.768787:0.099744:0.768787:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.004198:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.004210:0.008032:0.007173:0.008055:0.004210:0.011030:0.002352:0.002352:0.008055:0.004210:0.007608:0.007702:0.007914:0.007173:0.002352:0.003986:0.002352:0.006515:0.007644:0.004210:0.002352:0.011030:0.008020:0.008032:0.002352:0.003540:0.011030:0.007644:0.007173:0.003986:0.003257:0.004198:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.004198:0.008749:0.008032:0.003904
tabase syst Rev. 2012;11:CD002854.:@0.099744:0.791982:0.301309:0.791982:0.301309:0.779707:0.099744:0.779707:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
40.  Wang J, Tan L, Wang HF, Tan CC, Meng XF, Wang C, :@0.076226:0.802902:0.389492:0.802902:0.389492:0.790626:0.076226:0.790626:0.006279:0.006279:0.003022:0.003257:0.004680:0.011054:0.007796:0.006938:0.007679:0.002916:0.005433:0.003022:0.002916:0.004774:0.007796:0.006938:0.002916:0.005198:0.003022:0.002916:0.011054:0.007796:0.006938:0.007679:0.002916:0.007796:0.005468:0.003022:0.002916:0.004774:0.007796:0.006938:0.002916:0.009325:0.009325:0.003022:0.002916:0.010572:0.007408:0.006938:0.007679:0.002916:0.006926:0.005468:0.003022:0.002916:0.011054:0.007796:0.006938:0.007679:0.002916:0.009325:0.003022:0.003257
et al.:@0.389151:0.802902:0.416397:0.802902:0.416397:0.790626:0.389151:0.790626:0.007408:0.003751:0.002916:0.007796:0.002117:0.003257
 Anti-inflam:@0.416162:0.802902:0.477369:0.802902:0.477369:0.790626:0.416162:0.790626:0.002916:0.008467:0.006938:0.003751:0.002117:0.003669:0.002117:0.006938:0.002734:0.002734:0.007796:0.011030
-:@0.477134:0.802902:0.481038:0.802902:0.481038:0.790626:0.477134:0.790626:0.003904
matory drugs and risk of Alzheimer’s disease: An updated systematic :@0.099744:0.813821:0.484248:0.813821:0.484248:0.801546:0.099744:0.801546:0.010795:0.007796:0.003751:0.007467:0.003304:0.006068:0.003857:0.007820:0.003304:0.006914:0.007679:0.004327:0.003857:0.007796:0.006938:0.007820:0.003857:0.003304:0.002117:0.004327:0.005668:0.003857:0.007467:0.003457:0.003857:0.008467:0.002117:0.004762:0.006938:0.007408:0.002117:0.010795:0.007408:0.003304:0.003892:0.004327:0.003857:0.007820:0.002117:0.004327:0.007408:0.007796:0.004327:0.007408:0.003022:0.003857:0.008467:0.006938:0.003857:0.006914:0.007785:0.007820:0.007796:0.003751:0.007408:0.007820:0.003857:0.004327:0.006068:0.004327:0.003751:0.007408:0.010795:0.007796:0.003751:0.002117:0.007608:0.003257
review and meta-analysis. :@0.099744:0.824740:0.245582:0.824740:0.245582:0.812465:0.099744:0.812465:0.003304:0.007408:0.006279:0.002117:0.007408:0.009537:0.003022:0.007796:0.006938:0.007820:0.003022:0.010795:0.007408:0.003751:0.007796:0.003669:0.007796:0.006938:0.007796:0.002117:0.006068:0.004327:0.002117:0.004327:0.003022:0.003257
J Alzheimers Dis:@0.245347:0.824740:0.329661:0.824740:0.329661:0.812465:0.245347:0.812465:0.005433:0.003022:0.008467:0.002117:0.004762:0.006938:0.007408:0.002117:0.010795:0.007408:0.003304:0.004327:0.003022:0.008514:0.002117:0.004563
. 2015;44(2):385-96.:@0.329426:0.824740:0.432002:0.824740:0.432002:0.812465:0.329426:0.812465:0.003022:0.003022:0.006279:0.006279:0.006279:0.006279:0.003022:0.006279:0.006279:0.004104:0.006279:0.004104:0.003022:0.006279:0.006279:0.006279:0.003669:0.006279:0.006279:0.003257
41.  sheehan B. Assessment scales in dementia. :@0.076226:0.835660:0.348652:0.835660:0.348652:0.823385:0.076226:0.823385:0.006515:0.006515:0.003257:0.003257:0.003975:0.005856:0.007173:0.007644:0.007644:0.007173:0.008032:0.007173:0.003410:0.006750:0.003257:0.003410:0.008702:0.004563:0.004563:0.007644:0.004563:0.004563:0.011030:0.007644:0.007173:0.003986:0.003410:0.004563:0.007608:0.008032:0.002352:0.007644:0.004563:0.003422:0.002352:0.007173:0.003410:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257
Ther Adv Neurol Disord:@0.348817:0.835660:0.477734:0.835660:0.477734:0.823385:0.348817:0.823385:0.005009:0.007173:0.007644:0.003540:0.003410:0.008702:0.008055:0.006515:0.003410:0.008702:0.007644:0.007150:0.003540:0.007702:0.002352:0.003410:0.008749:0.002352:0.004563:0.007702:0.003540:0.008055
. :@0.477734:0.835660:0.484248:0.835660:0.484248:0.823385:0.477734:0.823385:0.003257:0.003257
2012;5(6):349-58.:@0.099744:0.846579:0.193759:0.846579:0.193759:0.834304:0.099744:0.834304:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
42.  Gauthier  s, Emre M, Farlow MR, Bullock  R, Grossberg GT,  potkin :@0.076226:0.857499:0.484248:0.857499:0.484248:0.845223:0.076226:0.845223:0.006515:0.006515:0.003257:0.003257:0.003975:0.010254:0.008032:0.007150:0.003986:0.007173:0.002352:0.007644:0.003540:0.003257:0.002799:0.005856:0.003257:0.006056:0.006303:0.011030:0.003540:0.007644:0.006056:0.010807:0.003257:0.006056:0.005703:0.008032:0.003540:0.002352:0.007702:0.009772:0.006056:0.010807:0.007138:0.003257:0.006056:0.006750:0.007150:0.002352:0.002352:0.007702:0.007608:0.005903:0.003257:0.002810:0.007138:0.003257:0.006056:0.010254:0.003540:0.007702:0.004563:0.004563:0.008020:0.007644:0.003540:0.007914:0.006056:0.010254:0.005009:0.003257:0.003257:0.002799:0.006961:0.007702:0.003986:0.005903:0.002352:0.007173:0.003257
sG.  strategies for  continued  successful treatment  of  Alzheimer’s :@0.099744:0.868418:0.484248:0.868418:0.484248:0.856143:0.099744:0.856143:0.005856:0.010254:0.003257:0.003257:0.002916:0.005856:0.003986:0.003540:0.008032:0.003986:0.007632:0.007914:0.002352:0.007644:0.004563:0.006174:0.003692:0.007702:0.003540:0.003257:0.002905:0.007608:0.007702:0.007173:0.003986:0.002352:0.007173:0.007150:0.007644:0.008055:0.003257:0.002905:0.004563:0.007150:0.007608:0.007608:0.007644:0.004563:0.004563:0.003692:0.007150:0.002352:0.006174:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.002905:0.007702:0.003692:0.003257:0.002905:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.003257
disease: switching cholinesterase  inhibitors. :@0.099744:0.879338:0.356649:0.879338:0.356649:0.867062:0.099744:0.867062:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.006738:0.004563:0.009772:0.002352:0.003986:0.007608:0.007173:0.002352:0.007173:0.007914:0.006738:0.007608:0.007173:0.007702:0.002352:0.002352:0.007173:0.007644:0.004563:0.003986:0.007644:0.003540:0.008032:0.004563:0.007644:0.003257:0.003469:0.002352:0.007173:0.007173:0.002352:0.008020:0.002352:0.003986:0.007702:0.003540:0.004563:0.003257:0.003257
Curr  Med Res Opin:@0.360129:0.879338:0.477734:0.879338:0.477734:0.867062:0.360129:0.867062:0.009560:0.007150:0.003540:0.003540:0.003257:0.003469:0.010807:0.007644:0.008055:0.006738:0.007138:0.007644:0.004563:0.006738:0.010219:0.008020:0.002352:0.007173
. :@0.477734:0.879338:0.484248:0.879338:0.484248:0.867062:0.477734:0.867062:0.003257:0.003257
2003;19(8):707-14.:@0.099744:0.890257:0.200274:0.890257:0.200274:0.877982:0.099744:0.877982:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
43.  Di santo sG, prinelli F, Adorni F, Caltagirone C, Musicco M. A meta-:@0.076226:0.901176:0.481003:0.901176:0.481003:0.888901:0.076226:0.888901:0.006515:0.006515:0.003257:0.003257:0.003975:0.008749:0.002352:0.003469:0.005856:0.008032:0.007173:0.003986:0.007702:0.003469:0.005856:0.010254:0.003257:0.003469:0.006961:0.003540:0.002352:0.007173:0.007644:0.002352:0.002352:0.002352:0.003469:0.005703:0.003257:0.003469:0.008702:0.008055:0.007702:0.003540:0.007173:0.002352:0.003457:0.005703:0.003257:0.003469:0.009560:0.008032:0.002352:0.003986:0.008032:0.007914:0.002352:0.003540:0.007702:0.007173:0.007644:0.003469:0.009560:0.003257:0.003469:0.010807:0.007150:0.004563:0.002352:0.007608:0.007608:0.007702:0.003469:0.010807:0.003257:0.003469:0.008702:0.003469:0.011030:0.007644:0.003986:0.008032:0.003904
analysis  of  the  efficacy  of  donepezil,  rivastigmine,  galantamine, :@0.099744:0.912096:0.484260:0.912096:0.484260:0.899821:0.099744:0.899821:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.003257:0.002869:0.007702:0.003692:0.003257:0.002857:0.003986:0.007173:0.007644:0.003257:0.002846:0.007644:0.003692:0.002863:0.002863:0.007608:0.008032:0.007608:0.006303:0.003257:0.002857:0.007702:0.003692:0.003257:0.002857:0.008055:0.007702:0.007173:0.007644:0.008020:0.007644:0.004998:0.002352:0.002352:0.003257:0.003257:0.002857:0.003540:0.002352:0.006515:0.008032:0.004563:0.003986:0.002352:0.007914:0.011030:0.002352:0.007173:0.007644:0.003257:0.003257:0.002857:0.007914:0.008032:0.002352:0.008032:0.007173:0.003986:0.008032:0.011030:0.002352:0.007173:0.007644:0.003257:0.003257
and memantine in relation to severity of Alzheimer’s disease. :@0.099744:0.923015:0.450969:0.923015:0.450969:0.910740:0.099744:0.910740:0.008032:0.007173:0.008055:0.003810:0.011030:0.007644:0.011030:0.008032:0.007173:0.003986:0.002352:0.007173:0.007644:0.003810:0.002352:0.007173:0.003810:0.003540:0.007644:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.003810:0.003986:0.007702:0.003810:0.004563:0.007644:0.006515:0.007644:0.003540:0.002352:0.003986:0.006303:0.003810:0.007702:0.003692:0.003810:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.003810:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257
J Alz-:@0.451534:0.923015:0.480967:0.923015:0.480967:0.910740:0.451534:0.910740:0.005668:0.003810:0.008702:0.002352:0.004998:0.003904
heimers Dis:@0.099744:0.933935:0.162609:0.933935:0.162609:0.921659:0.099744:0.921659:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004563:0.003257:0.008749:0.002352:0.004563
. 2013;35(2):349-61.:@0.162609:0.933935:0.269654:0.933935:0.269654:0.921659:0.162609:0.921659:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
44.  smith DA. Treatment of Alzheimer’s disease in the long-term-care :@0.076226:0.944854:0.484236:0.944854:0.484236:0.932579:0.076226:0.932579:0.006515:0.006515:0.003257:0.003257:0.003975:0.005856:0.011030:0.002352:0.003986:0.007173:0.004927:0.008749:0.008702:0.003257:0.004927:0.005009:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.004915:0.007702:0.003692:0.004927:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.004927:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.004939:0.002352:0.007173:0.004927:0.003986:0.007173:0.007644:0.004927:0.002352:0.007702:0.007173:0.007914:0.003904:0.003986:0.007644:0.003540:0.011030:0.003904:0.007608:0.008032:0.003540:0.007644:0.003257
setting. :@0.542598:0.082498:0.586730:0.082498:0.586730:0.070222:0.542598:0.070222:0.004563:0.007644:0.003986:0.003986:0.002352:0.007173:0.007914:0.003257:0.003257
Am J Health Syst Pharm:@0.586718:0.082498:0.719809:0.082498:0.719809:0.070222:0.586718:0.070222:0.008702:0.011030:0.003257:0.005668:0.003257:0.008032:0.007644:0.008032:0.002352:0.003986:0.007173:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.006961:0.007173:0.008032:0.003540:0.011030
. 2009;66(10):899-907.:@0.719798:0.082498:0.839871:0.082498:0.839871:0.070222:0.719798:0.070222:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
45.  Loy  C,  schneider  L.  Galantamine for  Alzheimer’s  disease and :@0.519079:0.093399:0.927102:0.093399:0.927102:0.081124:0.519079:0.081124:0.006515:0.006515:0.003257:0.003257:0.003975:0.005433:0.007702:0.006303:0.003257:0.004492:0.009560:0.003257:0.003257:0.004504:0.005856:0.007608:0.007173:0.007173:0.007644:0.002352:0.008055:0.007644:0.003540:0.003257:0.004492:0.005433:0.003257:0.003257:0.004492:0.010254:0.008032:0.002352:0.008032:0.007173:0.003986:0.008032:0.011030:0.002352:0.007173:0.007644:0.007761:0.003692:0.007702:0.003540:0.003257:0.004492:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.003257:0.004492:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.007761:0.008032:0.007173:0.008055:0.003257
mild cognitive  impairment.  Cochrane  Database  syst Rev. :@0.542598:0.104301:0.927090:0.104301:0.927090:0.092025:0.542598:0.092025:0.011030:0.002352:0.002352:0.008055:0.012512:0.007608:0.007702:0.007914:0.007173:0.002352:0.003986:0.002352:0.006515:0.007644:0.003257:0.009243:0.002352:0.011030:0.008020:0.008032:0.002352:0.003540:0.011030:0.007644:0.007173:0.003986:0.003257:0.003257:0.009243:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003257:0.009243:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.009255:0.005856:0.006303:0.004563:0.003986:0.012512:0.007138:0.007644:0.006515:0.003257:0.003257
2006(1):CD001747.:@0.542598:0.115202:0.647761:0.115202:0.647761:0.102927:0.542598:0.102927:0.006515:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
46.  Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer’s dis-:@0.519079:0.126104:0.923832:0.126104:0.923832:0.113828:0.519079:0.113828:0.006515:0.006515:0.003257:0.003257:0.003975:0.006750:0.002352:0.003540:0.005903:0.004563:0.004810:0.005668:0.003257:0.004810:0.008032:0.008032:0.003540:0.006515:0.007644:0.006303:0.004810:0.007138:0.005668:0.003257:0.004810:0.008749:0.007702:0.007173:0.007644:0.008020:0.007644:0.004998:0.002352:0.002352:0.004810:0.003692:0.007702:0.003540:0.004798:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.004810:0.008055:0.007150:0.007644:0.004810:0.003986:0.007702:0.004798:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.004798:0.008055:0.002352:0.004563:0.003904
ease. Cochrane Database syst Rev. 2006(1):CD001190.:@0.542598:0.137005:0.855935:0.137005:0.855935:0.124730:0.542598:0.124730:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003257:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
47.  Birks J,  Grimley Evans J,  Iakovidou V, Tsolaki  M,  Holt FE.  Rivastig-:@0.519079:0.147907:0.923844:0.147907:0.923844:0.135631:0.519079:0.135631:0.006515:0.006515:0.003257:0.003257:0.003975:0.006750:0.002352:0.003540:0.005903:0.004563:0.005691:0.005668:0.003257:0.003257:0.002422:0.010254:0.003540:0.002352:0.011030:0.002352:0.007644:0.006303:0.005691:0.006303:0.006515:0.008032:0.007173:0.004563:0.005691:0.005668:0.003257:0.003257:0.002422:0.002658:0.008032:0.005903:0.007702:0.006515:0.002352:0.008055:0.007702:0.007150:0.005691:0.008255:0.003257:0.005691:0.005009:0.004563:0.007702:0.002352:0.008032:0.005903:0.002352:0.003257:0.002434:0.010807:0.003257:0.003257:0.002422:0.008032:0.007702:0.002352:0.003986:0.005691:0.005703:0.006303:0.003257:0.003257:0.002422:0.007138:0.002352:0.006515:0.008032:0.004563:0.003986:0.002352:0.007937:0.003904
mine for  Alzheimer’s disease. Cochrane  Database  syst Rev. :@0.542598:0.158808:0.927113:0.158808:0.927113:0.146533:0.542598:0.146533:0.011030:0.002352:0.007173:0.007644:0.009596:0.003692:0.007702:0.003540:0.003257:0.006326:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.009596:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.009596:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003257:0.006326:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.006338:0.005856:0.006303:0.004563:0.003986:0.009596:0.007138:0.007644:0.006515:0.003257:0.003257
2009(2):CD001191.:@0.542598:0.169709:0.647761:0.169709:0.647761:0.157434:0.542598:0.157434:0.006515:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
48.  Levy RH, Collins C. Risk and predictability of drug interactions in the :@0.519079:0.180611:0.927090:0.180611:0.927090:0.168336:0.519079:0.168336:0.006515:0.006515:0.003257:0.003257:0.003975:0.005433:0.007644:0.006515:0.006303:0.003434:0.007138:0.008032:0.003257:0.003434:0.009560:0.007702:0.002352:0.002352:0.002352:0.007173:0.004563:0.003434:0.009560:0.003257:0.003434:0.007138:0.002352:0.004563:0.005903:0.003434:0.008032:0.007173:0.008055:0.003434:0.008020:0.003540:0.007644:0.008055:0.002352:0.007608:0.003986:0.008032:0.008020:0.002352:0.002352:0.002352:0.003986:0.006303:0.003434:0.007702:0.003692:0.003422:0.008055:0.003540:0.007150:0.007914:0.003422:0.002352:0.007173:0.003986:0.007644:0.003540:0.008032:0.007608:0.003986:0.002352:0.007702:0.007173:0.004563:0.003422:0.002352:0.007173:0.003434:0.003986:0.007173:0.007644:0.003257
elderly. :@0.542598:0.191512:0.587000:0.191512:0.587000:0.179237:0.542598:0.179237:0.007644:0.002352:0.008055:0.007644:0.003540:0.002352:0.006303:0.003257:0.003257
Int Rev Neurobiol:@0.587000:0.191512:0.683791:0.191512:0.683791:0.179237:0.587000:0.179237:0.002658:0.007173:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.008702:0.007644:0.007150:0.003540:0.007702:0.008020:0.002352:0.007702:0.002352
. 2007;81:235-51.:@0.683779:0.191512:0.775631:0.191512:0.775631:0.179237:0.683779:0.179237:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
49.  schneider Ls, Mangialasche F, Andreasen N, Feldman H, Giacobini :@0.519079:0.202414:0.927078:0.202414:0.927078:0.190139:0.519079:0.190139:0.006515:0.006515:0.003257:0.003257:0.003975:0.005856:0.007608:0.007173:0.007173:0.007644:0.002352:0.008055:0.007644:0.003540:0.003422:0.005433:0.005856:0.003257:0.003422:0.010807:0.008032:0.007173:0.007914:0.002352:0.008032:0.002352:0.008032:0.004563:0.007608:0.007173:0.007644:0.003434:0.005703:0.003257:0.003422:0.008702:0.007173:0.008055:0.003540:0.007644:0.008032:0.004563:0.007644:0.007173:0.003422:0.008702:0.003257:0.003422:0.005703:0.007644:0.002352:0.008055:0.011030:0.008032:0.007173:0.003422:0.008032:0.003257:0.003422:0.010254:0.002352:0.008032:0.007608:0.007702:0.008020:0.002352:0.007173:0.002352:0.003257
E, Jones R, :@0.542598:0.213315:0.605098:0.213315:0.605098:0.201040:0.542598:0.201040:0.006303:0.003257:0.003269:0.005668:0.007702:0.007173:0.007644:0.004563:0.003269:0.007138:0.003257:0.003257
et al:@0.605110:0.213315:0.630392:0.213315:0.630392:0.201040:0.605110:0.201040:0.007644:0.003986:0.003269:0.008032:0.002352
. Clinical trials and late-stage drug development for :@0.630392:0.213315:0.927090:0.213315:0.927090:0.201040:0.630392:0.201040:0.003257:0.003269:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003281:0.003986:0.003540:0.002352:0.008032:0.002352:0.004563:0.003281:0.008032:0.007173:0.008055:0.003269:0.002352:0.008032:0.003986:0.007644:0.003904:0.004563:0.003986:0.008032:0.007914:0.007644:0.003269:0.008055:0.003540:0.007150:0.007914:0.003269:0.008055:0.007644:0.006515:0.007644:0.002352:0.007702:0.008020:0.011030:0.007644:0.007173:0.003986:0.003269:0.003692:0.007702:0.003540:0.003257
Alzheimer’s disease: an appraisal from 1984 to 2014. :@0.542598:0.224217:0.846845:0.224217:0.846845:0.211941:0.542598:0.211941:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.004222:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007655:0.003257:0.004222:0.008032:0.007173:0.004222:0.008032:0.008020:0.008020:0.003540:0.008032:0.002352:0.004563:0.008032:0.002352:0.004233:0.003692:0.003540:0.007702:0.011030:0.004222:0.006515:0.006515:0.006515:0.006515:0.004233:0.003986:0.007702:0.004222:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
J Intern Med.:@0.847797:0.224217:0.923832:0.224217:0.923832:0.211941:0.847797:0.211941:0.005668:0.004222:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.004210:0.010807:0.007644:0.008055:0.003257
 :@0.923832:0.224217:0.927090:0.224217:0.927090:0.211941:0.923832:0.211941:0.003257
2014;275(3):251-83.:@0.542598:0.235118:0.649642:0.235118:0.649642:0.222843:0.542598:0.222843:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
50.  National Institute for Health and Clinical Excellence. Dementia: sup-:@0.519079:0.246020:0.923832:0.246020:0.923832:0.233744:0.519079:0.233744:0.006515:0.006515:0.003257:0.003257:0.003975:0.008702:0.008032:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.002775:0.002658:0.007173:0.004563:0.003986:0.002352:0.003986:0.007150:0.003986:0.007644:0.002775:0.003692:0.007702:0.003540:0.002763:0.008032:0.007644:0.008032:0.002352:0.003986:0.007173:0.002775:0.008032:0.007173:0.008055:0.002775:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.002775:0.006303:0.005644:0.007608:0.007644:0.002352:0.002352:0.007644:0.007173:0.007608:0.007644:0.003257:0.002775:0.008749:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.002775:0.005856:0.007150:0.008020:0.003904
porting people with dementia and their carers in health and social :@0.542598:0.256921:0.927090:0.256921:0.927090:0.244646:0.542598:0.244646:0.008020:0.007702:0.003540:0.003986:0.002352:0.007173:0.007914:0.003528:0.008020:0.007644:0.007702:0.008020:0.002352:0.007644:0.003540:0.009772:0.002352:0.003986:0.007173:0.003540:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003528:0.008032:0.007173:0.008055:0.003540:0.003986:0.007173:0.007644:0.002352:0.003540:0.003528:0.007608:0.008032:0.003540:0.007644:0.003540:0.004563:0.003528:0.002352:0.007173:0.003540:0.007173:0.007644:0.008032:0.002352:0.003986:0.007173:0.003528:0.008032:0.007173:0.008055:0.003540:0.004563:0.007702:0.007608:0.002352:0.008032:0.002352:0.003257
care: National Institute for Health and Care Excellence; 2006 [cited :@0.542598:0.267823:0.927078:0.267823:0.927078:0.255547:0.542598:0.255547:0.007608:0.008032:0.003540:0.007644:0.003257:0.003340:0.008702:0.008032:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003340:0.002658:0.007173:0.004563:0.003986:0.002352:0.003986:0.007150:0.003986:0.007644:0.003340:0.003692:0.007702:0.003540:0.003340:0.008032:0.007644:0.008032:0.002352:0.003986:0.007173:0.003340:0.008032:0.007173:0.008055:0.003340:0.009560:0.008032:0.003540:0.007644:0.003340:0.006303:0.005644:0.007608:0.007644:0.002352:0.002352:0.007644:0.007173:0.007608:0.007644:0.003257:0.003340:0.006515:0.006515:0.006515:0.006515:0.003351:0.004127:0.007608:0.002352:0.003986:0.007644:0.008055:0.003257
2014]. Available from: https://www.nice.org.uk/guidance/cg42.:@0.542598:0.278724:0.904371:0.278724:0.904371:0.266449:0.542598:0.266449:0.006515:0.006515:0.006515:0.006515:0.004127:0.003257:0.003257:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.003257:0.003692:0.003540:0.007702:0.011030:0.003257:0.003257:0.007173:0.003986:0.003986:0.008020:0.004563:0.003257:0.005139:0.005139:0.009772:0.009772:0.009772:0.003257:0.007173:0.002352:0.007608:0.007644:0.003257:0.007702:0.003540:0.007914:0.003257:0.007150:0.005903:0.005139:0.007914:0.007150:0.002352:0.008055:0.008032:0.007173:0.007608:0.007644:0.005139:0.007608:0.007914:0.006515:0.006503:0.003257
51.  Rainer M, Mucke HA, Kruger-Rainer  C, Kraxberger  E, Haushofer :@0.519079:0.289626:0.927102:0.289626:0.927102:0.277350:0.519079:0.277350:0.006515:0.006515:0.003257:0.003257:0.003975:0.007138:0.008032:0.002352:0.007173:0.007644:0.003540:0.006667:0.010807:0.003257:0.006667:0.010807:0.007150:0.007608:0.005903:0.007644:0.006667:0.008032:0.008702:0.003257:0.006667:0.006950:0.003540:0.007150:0.007914:0.007644:0.003540:0.003904:0.007138:0.008032:0.002352:0.007173:0.007644:0.003540:0.003257:0.003398:0.009560:0.003257:0.006667:0.006950:0.003540:0.008032:0.005644:0.008020:0.007644:0.003540:0.007914:0.007644:0.003540:0.003257:0.003398:0.006303:0.003257:0.006667:0.008032:0.008032:0.007150:0.004563:0.007173:0.007702:0.003692:0.007644:0.003540:0.003257
M,  Jellinger  KA.  Cognitive  relapse after  discontinuation  of  drug :@0.542598:0.300527:0.927078:0.300527:0.927078:0.288252:0.542598:0.288252:0.010807:0.003257:0.003257:0.003281:0.005668:0.007644:0.002352:0.002352:0.002352:0.007173:0.007914:0.007644:0.003540:0.003257:0.003281:0.006950:0.008702:0.003257:0.003257:0.003281:0.009560:0.007702:0.007914:0.007173:0.002352:0.003986:0.002352:0.006515:0.007644:0.003257:0.003281:0.003540:0.007644:0.002352:0.008032:0.008020:0.004563:0.007644:0.006550:0.008032:0.003692:0.003986:0.007644:0.003540:0.003257:0.003281:0.008055:0.002352:0.004563:0.007608:0.007702:0.007173:0.003986:0.002352:0.007173:0.007150:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.003281:0.007702:0.003692:0.003257:0.003281:0.008055:0.003540:0.007150:0.007914:0.003257
therapy in Alzheimer’s disease:  Cholinesterase inhibitors versus  :@0.542598:0.311429:0.927102:0.311429:0.927102:0.299153:0.542598:0.299153:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.008279:0.002352:0.007173:0.008279:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.008279:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257:0.005033:0.009560:0.007173:0.007702:0.002352:0.002352:0.007173:0.007644:0.004563:0.003986:0.007644:0.003540:0.008032:0.004563:0.007644:0.008279:0.002352:0.007173:0.007173:0.002352:0.008020:0.002352:0.003986:0.007702:0.003540:0.004563:0.008279:0.006515:0.007644:0.003540:0.004563:0.007150:0.004563:0.000000:0.003257
nootropics. :@0.542598:0.322330:0.609461:0.322330:0.609461:0.310055:0.542598:0.310055:0.007173:0.007702:0.007702:0.003986:0.003540:0.007702:0.008020:0.002352:0.007608:0.004563:0.003257:0.003257
J Neural Transm. :@0.609449:0.322330:0.704910:0.322330:0.704910:0.310055:0.609449:0.310055:0.005668:0.003257:0.008702:0.007644:0.007150:0.003540:0.008032:0.002352:0.003257:0.005009:0.003540:0.008032:0.007173:0.004563:0.011030:0.003257:0.003257
2001;108(11):1327-33.:@0.704899:0.322330:0.824972:0.322330:0.824972:0.310055:0.704899:0.310055:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
52.  Larner AJ. Cholinesterase inhibitors: Beyond Alzheimer’s disease. :@0.519079:0.333232:0.908075:0.333232:0.908075:0.320956:0.519079:0.320956:0.006515:0.006515:0.003257:0.003257:0.003975:0.005433:0.008032:0.003540:0.007173:0.007644:0.003540:0.003163:0.008702:0.005668:0.003257:0.003163:0.009560:0.007173:0.007702:0.002352:0.002352:0.007173:0.007644:0.004563:0.003986:0.007644:0.003540:0.008032:0.004563:0.007644:0.003163:0.002352:0.007173:0.007173:0.002352:0.008020:0.002352:0.003986:0.007702:0.003540:0.004563:0.003257:0.003163:0.006750:0.007644:0.006303:0.007702:0.007173:0.008055:0.003163:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.003163:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257
Ex-:@0.907993:0.333232:0.923844:0.333232:0.923844:0.320956:0.907993:0.320956:0.006303:0.005644:0.003904
pert Rev Neurother.:@0.542598:0.344133:0.653934:0.344133:0.653934:0.331858:0.542598:0.331858:0.008020:0.007644:0.003540:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.008702:0.007644:0.007150:0.003540:0.007702:0.003986:0.007173:0.007644:0.003540:0.003257
 2010;10(11):1699-705.:@0.653911:0.344133:0.777242:0.344133:0.777242:0.331858:0.653911:0.331858:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
53.  Kang H, Zhao F, You  L, Giorgetta  C,  sarkhel  s, :@0.519079:0.355034:0.820457:0.355034:0.820457:0.342759:0.519079:0.342759:0.006515:0.006515:0.003257:0.003257:0.003975:0.006950:0.008032:0.007173:0.007914:0.005268:0.008032:0.003257:0.005268:0.005644:0.007173:0.008032:0.007702:0.005268:0.005703:0.003257:0.005268:0.006961:0.007702:0.007150:0.003257:0.001999:0.005433:0.003257:0.005268:0.010254:0.002352:0.007702:0.003540:0.007914:0.007644:0.003986:0.003986:0.008032:0.003257:0.001999:0.009560:0.003257:0.003257:0.002011:0.005856:0.008032:0.003540:0.005903:0.007173:0.007644:0.002352:0.003257:0.002011:0.005856:0.003257:0.003257
et al:@0.822468:0.355034:0.849749:0.355034:0.849749:0.342759:0.822468:0.342759:0.007644:0.003986:0.005268:0.008032:0.002352
.  pseudo-de-:@0.849749:0.355034:0.923856:0.355034:0.923856:0.342759:0.849749:0.342759:0.003257:0.003257:0.002011:0.006961:0.004563:0.007644:0.007150:0.008055:0.007702:0.003904:0.008055:0.007644:0.003904
mentia:  A neuropsychological review. :@0.542598:0.365936:0.770598:0.365936:0.770598:0.353661:0.542598:0.353661:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257:0.003057:0.008702:0.006326:0.007173:0.007644:0.007150:0.003540:0.007702:0.008020:0.004551:0.006303:0.007608:0.007173:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.008032:0.002352:0.006326:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.003257
Ann  Indian Acad  Neurol:@0.773655:0.365936:0.920587:0.365936:0.920587:0.353661:0.773655:0.353661:0.008702:0.007173:0.007173:0.003257:0.003057:0.002658:0.007173:0.008055:0.002352:0.008032:0.007173:0.006326:0.008702:0.007608:0.008032:0.008055:0.003257:0.003057:0.008702:0.007644:0.007150:0.003540:0.007702:0.002352
. :@0.920587:0.365936:0.927102:0.365936:0.927102:0.353661:0.920587:0.353661:0.003257:0.003257
2014;17(2):147-54.:@0.542598:0.376837:0.643127:0.376837:0.643127:0.364562:0.542598:0.364562:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
54.  Massoud F, Desmarais JE, Gauthier s. switching cholinesterase inhibi-:@0.519079:0.387739:0.923821:0.387739:0.923821:0.375463:0.519079:0.375463:0.006515:0.006515:0.003257:0.003257:0.003975:0.010689:0.007914:0.004445:0.004445:0.007585:0.007032:0.007937:0.003246:0.005586:0.003140:0.003246:0.008631:0.007526:0.004445:0.010913:0.007914:0.003422:0.007914:0.002234:0.004445:0.003246:0.005550:0.006185:0.003140:0.003246:0.010136:0.007914:0.007032:0.003869:0.007056:0.002234:0.007526:0.003422:0.003269:0.005739:0.003140:0.003246:0.005739:0.009654:0.002234:0.003869:0.007491:0.007056:0.002234:0.007056:0.007796:0.003246:0.007491:0.007056:0.007585:0.002234:0.002234:0.007056:0.007526:0.004445:0.003869:0.007526:0.003422:0.007914:0.004445:0.007526:0.003246:0.002234:0.007056:0.007056:0.002234:0.007902:0.002234:0.003904
tors in older adults with dementia. :@0.542586:0.398640:0.733156:0.398640:0.733156:0.386365:0.542586:0.386365:0.003869:0.007585:0.003422:0.004445:0.003128:0.002234:0.007056:0.003128:0.007585:0.002234:0.007937:0.007526:0.003422:0.003128:0.007914:0.007937:0.007032:0.002234:0.003869:0.004445:0.003128:0.009654:0.002234:0.003869:0.007056:0.003128:0.007937:0.007526:0.010913:0.007526:0.007056:0.003869:0.002234:0.007914:0.003140:0.003257
Int Psychogeriatr:@0.733027:0.398640:0.825525:0.398640:0.825525:0.386365:0.733027:0.386365:0.002540:0.007056:0.003869:0.003128:0.006844:0.004445:0.006185:0.007491:0.007056:0.007585:0.007796:0.007526:0.003422:0.002234:0.007914:0.003869:0.003540
. 2011;23(3):372-8.:@0.825408:0.398640:0.923809:0.398640:0.923809:0.386365:0.825408:0.386365:0.003140:0.003128:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.006397:0.004222:0.006397:0.004222:0.003140:0.006397:0.006397:0.006397:0.003786:0.006397:0.003257
55.  Wilkinson D, Wirth Y, Goebel C. Memantine in patients with moderate :@0.519067:0.409542:0.927137:0.409542:0.927137:0.397266:0.519067:0.397266:0.006397:0.006397:0.003140:0.003257:0.004327:0.011171:0.002234:0.002234:0.005786:0.002234:0.007056:0.004445:0.007585:0.007056:0.002799:0.008631:0.003140:0.002799:0.011171:0.002234:0.003422:0.003869:0.007056:0.002799:0.006844:0.003140:0.002799:0.010136:0.007585:0.007526:0.007902:0.007526:0.002234:0.002799:0.009443:0.003140:0.002799:0.010689:0.007526:0.010913:0.007914:0.007056:0.003869:0.002234:0.007056:0.007526:0.002799:0.002234:0.007056:0.002799:0.007902:0.007914:0.003869:0.002234:0.007526:0.007056:0.003869:0.004445:0.002799:0.009654:0.002234:0.003869:0.007056:0.002799:0.010913:0.007585:0.007937:0.007526:0.003422:0.007914:0.003869:0.007644:0.003257
to severe Alzheimer’s disease: Meta-analyses using realistic definitions :@0.542586:0.420443:0.927102:0.420443:0.927102:0.408168:0.542586:0.408168:0.003869:0.007585:0.002552:0.004445:0.007526:0.006397:0.007526:0.003422:0.007526:0.002552:0.008584:0.002234:0.004880:0.007056:0.007526:0.002234:0.010913:0.007526:0.003422:0.004010:0.004445:0.002552:0.007937:0.002234:0.004445:0.007526:0.007914:0.004445:0.007526:0.003140:0.002552:0.010689:0.007526:0.003869:0.007914:0.003786:0.007914:0.007056:0.007914:0.002234:0.006185:0.004445:0.007526:0.004445:0.002552:0.007032:0.004445:0.002234:0.007056:0.007796:0.002552:0.003422:0.007526:0.007914:0.002234:0.002234:0.004445:0.003869:0.002234:0.007491:0.002552:0.007937:0.007526:0.002805:0.002805:0.007056:0.002234:0.003869:0.002234:0.007585:0.007056:0.004563:0.003257
of response. :@0.542586:0.431345:0.613188:0.431345:0.613188:0.419069:0.542586:0.419069:0.007585:0.003575:0.003140:0.003422:0.007526:0.004445:0.007902:0.007585:0.007056:0.004445:0.007526:0.003140:0.003257
Dement Geriatr Cogn Disord:@0.613071:0.431345:0.772785:0.431345:0.772785:0.419069:0.613071:0.419069:0.008631:0.007526:0.010913:0.007526:0.007056:0.003869:0.003140:0.010136:0.007526:0.003422:0.002234:0.007914:0.003869:0.003422:0.003140:0.009443:0.007585:0.007796:0.007056:0.003140:0.008631:0.002234:0.004445:0.007585:0.003422:0.008055
. 2014;37(1-2):71-85.:@0.772667:0.431345:0.881264:0.431345:0.881264:0.419069:0.772667:0.419069:0.003140:0.003140:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.006397:0.004222:0.006397:0.003786:0.006397:0.004222:0.003140:0.006397:0.006397:0.003786:0.006397:0.006397:0.003257
56.  Guzior N, Wieckowska A, panek D, Malawska B. Recent development :@0.519067:0.442246:0.927113:0.442246:0.927113:0.429971:0.519067:0.429971:0.006397:0.006397:0.003140:0.003257:0.004327:0.010136:0.007032:0.004880:0.002234:0.007585:0.003422:0.002516:0.008584:0.003140:0.002516:0.011171:0.002234:0.007526:0.007491:0.005786:0.007585:0.009654:0.004445:0.005786:0.007914:0.002516:0.008584:0.003140:0.002516:0.006844:0.007914:0.007056:0.007526:0.005786:0.002516:0.008631:0.003140:0.002516:0.010689:0.007914:0.002234:0.007914:0.009654:0.004445:0.005786:0.007914:0.002516:0.006632:0.003140:0.002516:0.007020:0.007526:0.007491:0.007526:0.007056:0.003869:0.002516:0.007937:0.007526:0.006397:0.007526:0.002234:0.007585:0.007902:0.010913:0.007526:0.007056:0.003986:0.003257
of multifunctional agents as potential drug candidates for the treat-:@0.542586:0.453148:0.923868:0.453148:0.923868:0.440872:0.542586:0.440872:0.007585:0.003575:0.003622:0.010913:0.007032:0.002234:0.003869:0.002234:0.003575:0.007032:0.007056:0.007491:0.003869:0.002234:0.007585:0.007056:0.007914:0.002234:0.003622:0.007914:0.007796:0.007526:0.007056:0.003869:0.004445:0.003622:0.007914:0.004445:0.003622:0.007902:0.007585:0.003869:0.007526:0.007056:0.003869:0.002234:0.007914:0.002234:0.003622:0.007937:0.003422:0.007032:0.007796:0.003622:0.007491:0.007914:0.007056:0.007937:0.002234:0.007937:0.007914:0.003869:0.007526:0.004445:0.003622:0.003575:0.007585:0.003422:0.003622:0.003869:0.007056:0.007526:0.003622:0.003869:0.003422:0.007526:0.007914:0.003869:0.003904
ment of Alzheimer’s disease. :@0.542586:0.464049:0.703782:0.464049:0.703782:0.451774:0.542586:0.451774:0.010913:0.007526:0.007056:0.003869:0.003140:0.007585:0.003575:0.003140:0.008584:0.002234:0.004880:0.007056:0.007526:0.002234:0.010913:0.007526:0.003422:0.004010:0.004445:0.003140:0.007937:0.002234:0.004445:0.007526:0.007914:0.004445:0.007526:0.003140:0.003257
Curr Med Chem:@0.703664:0.464049:0.794469:0.464049:0.794469:0.451774:0.703664:0.451774:0.009443:0.007032:0.003422:0.003422:0.003140:0.010689:0.007526:0.007937:0.003140:0.009443:0.007056:0.007526:0.011030
. 2015;22(3):373-404.:@0.794351:0.464049:0.905559:0.464049:0.905559:0.451774:0.794351:0.451774:0.003140:0.003140:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.006397:0.004222:0.006397:0.004222:0.003140:0.006397:0.006397:0.006397:0.003786:0.006397:0.006397:0.006397:0.003257
57.  Geldenhuys WJ, Darvesh As.  pharmacotherapy of Alzheimer’s dis-:@0.519067:0.474951:0.923844:0.474951:0.923844:0.462675:0.519067:0.462675:0.006397:0.006397:0.003140:0.003257:0.004327:0.010136:0.007526:0.002234:0.007937:0.007526:0.007056:0.007056:0.007032:0.006185:0.004445:0.005127:0.011171:0.005550:0.003140:0.005127:0.008631:0.007914:0.003422:0.006397:0.007526:0.004445:0.007056:0.005127:0.008584:0.005739:0.003140:0.003257:0.001870:0.006844:0.007056:0.007914:0.003422:0.010913:0.007914:0.007491:0.007585:0.003869:0.007056:0.007526:0.003422:0.007914:0.007902:0.006185:0.005127:0.007585:0.003575:0.005127:0.008584:0.002234:0.004880:0.007056:0.007526:0.002234:0.010913:0.007526:0.003422:0.004010:0.004445:0.005127:0.007937:0.002234:0.004445:0.003904
ease: Current and future trends. :@0.542586:0.485852:0.722067:0.485852:0.722067:0.473577:0.542586:0.473577:0.007526:0.007914:0.004445:0.007526:0.003140:0.002787:0.009443:0.007032:0.003422:0.003422:0.007526:0.007056:0.003869:0.002787:0.007914:0.007056:0.007937:0.002787:0.003575:0.007032:0.003869:0.007032:0.003422:0.007526:0.002787:0.003869:0.003422:0.007526:0.007056:0.007937:0.004445:0.003140:0.003257
Expert Rev Neurother:@0.721597:0.485852:0.838684:0.485852:0.838684:0.473577:0.721597:0.473577:0.006185:0.005527:0.007902:0.007526:0.003422:0.003869:0.002787:0.007020:0.007526:0.006397:0.002787:0.008584:0.007526:0.007032:0.003422:0.007585:0.003869:0.007056:0.007526:0.003540
. 2015;15(1):3-5.:@0.838566:0.485852:0.923832:0.485852:0.923832:0.473577:0.838566:0.473577:0.003140:0.002787:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.006397:0.004222:0.006397:0.004222:0.003140:0.006397:0.003786:0.006397:0.003257
58.  Beinart N, Weinman J, Wade D, Brady R. Caregiver burden and psy-:@0.519067:0.496754:0.923797:0.496754:0.923797:0.484478:0.519067:0.484478:0.006515:0.006515:0.003257:0.003257:0.003975:0.006750:0.007644:0.002352:0.007173:0.008032:0.003540:0.003986:0.002881:0.008702:0.003257:0.002881:0.011289:0.007644:0.002352:0.007173:0.011030:0.008032:0.007173:0.002881:0.005668:0.003257:0.002881:0.011289:0.008032:0.008055:0.007644:0.002881:0.008749:0.003257:0.002881:0.006750:0.003540:0.008032:0.008055:0.006303:0.002881:0.007138:0.003257:0.002881:0.009560:0.008032:0.003540:0.007644:0.007914:0.002352:0.006515:0.007644:0.003540:0.002881:0.008020:0.007150:0.003540:0.008055:0.007644:0.007173:0.002881:0.008032:0.007173:0.008055:0.002881:0.008020:0.004563:0.006303:0.003904
choeducational interventions in Alzheimer’s disease: A review. :@0.542586:0.507655:0.902877:0.507655:0.902877:0.495380:0.542586:0.495380:0.007608:0.007173:0.007702:0.007644:0.008055:0.007150:0.007608:0.008032:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003916:0.002352:0.007173:0.003986:0.007644:0.003540:0.006515:0.007644:0.007173:0.003986:0.002352:0.007702:0.007173:0.004563:0.003904:0.002352:0.007173:0.003916:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.003916:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003916:0.008702:0.003916:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.003257
De-:@0.903536:0.507655:0.923832:0.507655:0.923832:0.495380:0.903536:0.495380:0.008749:0.007644:0.003904
ment Geriatr Cogn Dis Extra:@0.542586:0.518556:0.700313:0.518556:0.700313:0.506281:0.542586:0.506281:0.011030:0.007644:0.007173:0.003986:0.003257:0.010254:0.007644:0.003540:0.002352:0.008032:0.003986:0.003540:0.003257:0.009560:0.007702:0.007914:0.007173:0.003257:0.008749:0.002352:0.004563:0.003257:0.006303:0.005644:0.003986:0.003540:0.008032
. 2012;2(1):638-48.:@0.700301:0.518556:0.800831:0.518556:0.800831:0.506281:0.700301:0.506281:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257